The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report

被引：6
|
作者：
Yim, Ga Won [1 ]
Suh, Dong Hoon [2 ]
Kim, Jae-Weon [1 ]
Kim, Seung Cheol [3 ]
Kim, Young Tae [4 ]
机构：
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, South Korea
[3] Ewha Womans Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Dept Obstet & Gynecol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
来源：
JOURNAL OF GYNECOLOGIC ONCOLOGY | 2019年 / 30卷 / 04期
关键词：
Uterine Cervical Neoplasms; Ovarian Neoplasms; Endometrial Neoplasms; Molecular Targeted Therapy; Immunotherapy; PRIMARY SURGERY; OVARIAN-CANCER; MAINTENANCE THERAPY; ENDOMETRIAL CANCER; CERVICAL-CANCER; DOUBLE-BLIND; OPEN-LABEL; PHASE-II; CARCINOMA; RECURRENT;
D O I：
10.3802/jgo.2019.30.e91
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this meeting included recent clinical trials and updates in gynecologic oncology, advances in ovarian cancer treatment, targeted therapy and immunotherapy in gynecologic cancer, management of hereditary gynecologic cancer, and newly revised staging of cervical cancer. As expected, the ongoing debate regarding the recent clinical trial on minimally invasive surgery for early-stage cervical cancer was addressed throughout the congress and the initial outline of the KSGO position statement was open for discussion. The meeting was an opportunity for all participants to come together and explore scientific insights of gynecologic cancer.
引用
收藏
页数：17
相关论文
共 50 条
12345